WHO ICTRP trial
Study of WNT974 in combination with LGX818 and cetuximab in patients with…
EUCTR2014-002826-11-ES · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2014-002826-11-ES |
|---|---|
| Public title | Study of WNT974 in combination with LGX818 and cetuximab in patients with BRAF-mutant metastatic colorectal cancer (mCRC) and Wnt pathway mutations |
| Scientific title | A phase Ib/II multi-center, open label, dose escalation study of WNT974, LGX818 and cetuximab in patients with BRAFV600-mutant metastatic colorectal cancer harboring Wnt pathway mutations |
| Primary sponsor | Array BioPharma Inc. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): yes Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | France;Belgium;Spain;Netherlands;Italy;United Kingdom |
| Conditions | colorectal cancer MedDRA version: 20.0 Level: HLT Classification code 10010023 Term: Colorectal neoplasms malignant System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04] |
| Interventions | Product Code: WNT974 Pharmaceutical Form: Capsule, hard INN or Proposed INN: WNT974 CAS Number: WNT974 Current Sponsor code: WNT974 Other descriptive name: LGK974 Concentration unit: mg milligram(s) Concentration type: equal Concentration… |
| Registration date | Oct 22, 2014 |
| Target size | 55 |
| Secondary IDs | CWNT974X2102C;2014-002826-11-BE |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: